4D PHARMA PLC
14Patents
14Active
14Granted
49Portfolio score
Filing activity: Mar 8, 2018 → Feb 19, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10086021B2 | Compositions comprising bacterial strains | Human Necessities | 41 | Active |
| US10080772B2 | Compositions comprising bacterial strains | Emerging Cross-Sectional Technologies | 41 | Active |
| US10086020B2 | Compositions comprising bacterial strains | Emerging Cross-Sectional Technologies | 41 | Active |
| US10086022B2 | Compositions comprising bacterial strains | Human Necessities | 41 | Active |
| US10086023B2 | Compositions comprising bacterial strains | Human Necessities | 40 | Active |
| US10610548B2 | Compositions comprising bacterial strains | Emerging Cross-Sectional Technologies | 7 | Active |
| US10610549B2 | Composition comprising bacterial strains | Emerging Cross-Sectional Technologies | 6 | Active |
| US10485830B2 | Compositions comprising bacterial strains | Human Necessities | 1 | Active |
| US10543238B2 | Compositions comprising bacterial strains | Human Necessities | 1 | Active |
| US10898526B2 | Compositions comprising bacterial strains | Human Necessities | 0 | Active |
| US10960031B2 | Compositions comprising bacterial strains | Emerging Cross-Sectional Technologies | 0 | Active |
| US10583158B2 | Compositions comprising bacterial strains | Human Necessities | 0 | Active |
| US11224620B2 | Compositions comprising bacterial strains | Human Necessities | 0 | Active |
| US10967010B2 | Compositions comprising bacterial strains | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.